XML 10 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Loss (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net sales $ 358.9 $ 402.6
Cost of products sold 248.5 283.3
Gross profit 110.4 119.3
Operating costs and expenses:    
Selling, general and administrative expenses 94.2 95.0
Amortization of intangibles 10.6 10.9
Restructuring (0.3) 3.3
Total operating costs and expenses 104.5 109.2
Operating income [1] 5.9 10.1
Non-operating expense (income):    
Interest expense 13.3 13.9
Interest income (1.9) (2.4)
Non-operating pension expense 0.4 0.1
Other (income) expense, net (0.6) 1.8
Loss before income tax (5.3) (3.3)
Income tax expense 1.0 0.4
Net loss $ (6.3) $ (3.7)
Per share:    
Basic loss per share $ (0.07) $ (0.04)
Diluted loss per share $ (0.07) $ (0.04)
Weighted average number of shares outstanding:    
Basic (in shares) 95.7 94.9
Diluted (in shares) [2] 95.7 94.9
[1] Operating income is defined as i) net sales; ii) less cost of products sold; iii) less selling, general and administrative expenses; iv) less amortization of intangibles; v) less restructuring charges; and vi) less change in the fair value of contingent consideration.
[2] As a result of the net loss for the three months ended March 31, 2024 and 2023, diluted earnings per share does not include the effects of the stock awards for which the average market price for the period exceeds the exercised price, as their effect would have been anti-dilutive.